Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aelix Therapeutics

Request full access

Developing novel vaccines to cure HIV infection

Barcelona, SpainFounded 2014Biotech & Life Sciences

About Aelix Therapeutics

AELIX Therapeutics, headquartered in Barcelona, Spain, is a clinical-stage biotechnology company specializing in the development of therapeutic HIV vaccines. The company aims to integrate these vaccines into broader HIV cure and eradication strategies. Originating as a spin-off from HIVACAT, a renowned Catalan public-private consortium, AELIX leverages cutting-edge research to advance its mission. The company holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen, a key component in their vaccine development. AELIX Therapeutics primarily operates in the biotechnology and pharmaceutical markets, targeting healthcare providers and research institutions focused on HIV treatment and eradication. The business model revolves around the development, clinical testing, and eventual commercialization of its proprietary vaccines. Revenue generation is expected through licensing agreements, partnerships, and direct sales of the developed vaccines.

Source: Dealroom company data

At a glance

Status
Operational
Employees
1
Open positions
None listed
Dealroom signal
54.4/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Vaccines, Spinout, Biotech and Pharma, EIT Health, Hard Tech, DT and LS, science-based

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCEquity / VC Sep 2021 $2.2M $8.7M Undisclosed —
GRANT✓Other financing Jun 2017 $55K — Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Aelix Therapeutics website traffic

Latest recorded traffic for Aelix Therapeutics is 0 monthly website visits, down 100% over the last three months. Aelix Therapeutics's team grew 0% over the past year.

Latest monthly visits0 3-month web change-100% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Aelix Therapeutics in the Barcelona ecosystem

Live from Dealroom

The Aelix Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Ysios Capital

Other known investors6 additional known investors

  • August Pi i Sunyer Biomedical Research Institute
  • ICREA
  • IRSICAIXA
  • Caixa Capital Risc
  • CDTI Innvierte
  • Criteria Venture Tech
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇪🇸 Spain · Barcelona HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aelix Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aelix Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.